PW MEDTECH GROUP DL-0001
Research PW MEDTECH GROUP DL-0001 (PWE) on Bullrun: market cap EUR 160.60M, P/E 11.2, dividend yield 6.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerPWE
- ExchangeF
- CountryChina
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- CurrencyEUR
- Market capEUR 160.60M
- P/E11.2
- Dividend yield6.3%
- Financial periodFY2025
- RevenueEUR 823.51M
- Revenue growth7.1%
- Net incomeEUR 94.37M
- Free cash flowEUR 135.65M
- Gross margin49.5%
Valuation Snapshot
latest market cap is EUR 160.60M; P/E is 11.2; dividend yield is 6.3%.
About PW MEDTECH GROUP DL-0001
PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, the Americas, Africa, the rest of Asia, and internationally. It operates in three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company offers advanced infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens;
Frequently asked questions
What is PW MEDTECH GROUP DL-0001's market cap?
PW MEDTECH GROUP DL-0001's market capitalization is EUR 160.60M.
What is PW MEDTECH GROUP DL-0001's P/E ratio?
PW MEDTECH GROUP DL-0001's price-to-earnings (P/E) ratio is 11.2.
Does PW MEDTECH GROUP DL-0001 pay a dividend?
PW MEDTECH GROUP DL-0001 has a dividend yield of 6.3%.
What does PW MEDTECH GROUP DL-0001 do?
PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, the Americas, Africa, the rest of Asia, and internationally. It operates in three segments: Infusion Set Business; Blood Purification Business;